Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Long-Term Investments (2025)

Cumberland Pharmaceuticals' Long-Term Investments history spans 1 years, with the latest figure at $4.0 million for Q4 2025.

  • For Q4 2025, Long-Term Investments changed N/A year-over-year to $4.0 million; the TTM value through Dec 2025 reached $4.0 million, changed N/A, while the annual FY2025 figure was $4.0 million, N/A changed from the prior year.
  • Long-Term Investments for Q4 2025 was $4.0 million at Cumberland Pharmaceuticals.
  • Across five years, Long-Term Investments topped out at $4.0 million in Q4 2025 and bottomed at $4.0 million in Q4 2025.